Concepedia

Heidi Simmons

HS

6

Publications

785

Citations

6

H-Index

2005

Active since

Affiliations

Array BioPharma (United States)(Current)

University of Maryland, Baltimore

Heidi Simmons is an author at Array BioPharma (United States) specializing in medicine, tumor biology, and cell biology.

Top concepts

Publications per year

2005–2024

6

Publications

6

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers

Alex A. Adjei, Roger B. Cohen, Wilbur A. Franklin et al. · Journal of Clinical Oncology · 2008 · 572 citations · Full text

A phase 1 dose‐escalation study of ARRY‐520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias

H. Jean Khoury, Guillermo Garcia‐Manero, Gautam Borthakur et al. · Cancer · 2011 · 64 citations · Full text

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

Christopher Melani, Rahul Lakhotia, Stefania Pittaluga et al. · New England Journal of Medicine · 2024 · 58 citations · Full text

First-in-human phase 1 study of filanesib (ARRY-520), a kinesin spindle protein inhibitor, in patients with advanced solid tumors

Patricia LoRusso, Priscila Gonçalves, Lindsay Casetta et al. · Investigational New Drugs · 2015 · 46 citations

, , +8

The ImmuneRACE Study: A Prospective Multicohort Study of Immune Response Action to COVID-19 Events with the ImmuneCODE™ Open Access Database

Jennifer N. Dines, Thomas Manley, Emily Svejnoha et al. · 2020 · 27 citations · Full text

, , +22

Rows per page

1–5 of 6